STK31
Catalog Number: LS-C100782-400
400 µL / $401.00
Antibody: Rabbit Polyclonal
Applications: Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot
Reactivity: Human
Format: Liquid
The anti-STK31 antibody is used in Western blot to detect STK31 in rat testis tissue lysate.
STK31
Primary AntibodyLSBio Guarantee
| Antibody: | Rabbit Polyclonal |
| Applications: | Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot |
| Reactivity: | Human, Rat |
| Format: | Liquid |
$401.00each
Catalog Number: LS-C100781-400
Catalog Number: LS-C100781
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- STK31 antibody LS-C100781 is an unconjugated rabbit polyclonal antibody to STK31 (aa32-62) from human. It is reactive with human and rat. Validated for IHC and WB. Cited in 1 publication.
- Application
- IHC, IHC-P, WB
- Reactivity
- Hu, Rt
- Intended Use
- RUO
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Polyclonal Antibodies
- Alternative Names
- SGK396 | Serine/threonine kinase 31 | Sugen kinase 396 | STK31 | TDRD8 | Tudor domain containing 8
- Recommended Dilution: IHC-P
- 1:50 - 1:100
- Recommended Dilution: WB
- 1:1000
- UniProt Number
- Q9BXU1
- NCBI GenBank
- NM_031414, NP_113602.2
- SwissProt
- Q9BXU1
Target
- Target
- Human STK31
- Antigen Species
- Hu
- Epitope
- This STK31 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 32-62 amino acids from the N-terminal region of human STK31.
- Gene Name
- STK31
Antibody
- Host Species
- Rb
- Clonality
- Polyclonal
Immunogen
- Immunogen Type
- Pep
Format
- Conjugate/Label
- Unconj
- Format
- Liquid
- Formulation
- PBS, 0.09% Sodium Azide
- Volume
- 400 Microliter
- Preservative
- Yes
- Purification Method
- Prot A
Storage & Handling
- Storage Conditions
- Maintain refrigerated at 2°C to 8°C for up to 6 months. For long term storage store at -20°C.
- Recommended Storage Buffer
- PBS
Efficient identification of a novel cancer/testis antigen for immunotherapy using three-step microarray analysis. Yokoe T, Tanaka F, Mimori K, Inoue H, Ohmachi T, Kusunoki M, Mori M. Cancer research. 2008;68:1074-82. PubMed: 18281482
